Two phosphAte taRGets in End-stage Renal Disease Trial (TARGET)
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 104 participants.
Also called NCT01994733
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 104 participants
- Registry
-
NCT01994733
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Canada
- Registry status
- Completed
Technical summary
Registry record NCT01994733. Randomized; no masking; primary purpose treatment. Start 2014-01 (registry gives no type); primary completion 2015-04 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Two phosphAte taRGets in End-stage Renal Disease Trial (TARGET)
- Acronym
- TARGET
- Condition
- End-stage Renal Disease
- Intervention (Drug)
- Calcium carbonate ( Intensive phosphate control)
- Intervention (Drug)
- Calcium carbonate (Liberalized phosphate control)
- Lead sponsor
- Unity Health Toronto
- Collaborator
- Canadian Institutes of Health Research (CIHR)
Record details
- Record id
cardio:ct-nct01994733- Content hash
1569f0fa5549b2ce67fa2825e26b469a90b45fbc919ff67bc078656647750708